BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $566 From $500
Vertex Pharmaceuticals Analyst Ratings
Meta Platforms Analyst Ratings
Oppenheimer Adjusts Price Target on Meta Platforms to $525 From $500, Maintains Outperform Rating
New Street Adjusts Price Target on Alphabet to $210 From $200, Maintains Buy Rating
Progressive Analyst Ratings
Mastercard Analyst Ratings
Deutsche Bank Adjusts Price Target on Meta Platforms to $525 From $500
TD Cowen Reaffirms Their Hold Rating on Progressive (PGR)
RBC Lifts Price Target on Trane Technologies to $334 From $333, Keeps Sector Perform Rating
BMO Capital Adjusts Price Target on Progressive to $239 From $235, Maintains Outperform Rating
Microsoft Analyst Ratings
Piper Sandler Keeps Their Buy Rating on Intuit (INTU)
TD Cowen Adjusts Price Target on Microsoft to $495 From $470, Maintains Buy Rating
Mizuho Adjusts Price Target on Alphabet to $205 From $190, Maintains Outperform Rating
JPMorgan Adjusts Price Target on Mastercard to $500 From $510, Maintains Overweight Rating
Buy Rating for Mastercard: Steady Growth and Solid Financial Outlook Amid Market Challenges
Needham Remains a Buy on Amazon (AMZN)
Progressive's Revised Outlook: Hold Rating With Adjusted Target Amid Growth Concerns
Progressive's Strong Q2 Earnings and Growth Potential Affirm Buy Rating